Clinical evidence has suggested that the levels of the proinflammatory cytokines interleukin-6 (IL-6), interleukin-1β (IL-1β), and tumor necrosis factor-α (TNF-α) were higher in the serum and cerebrospinal fluid of PD patients [16, 17]. This evidence concerns the gene IL1B and Parkinson disease.